LAMEDITECH Co., Ltd. (462510.KQ)
8890.0
(-2.09%)
8890.0
(-2.09%)
| Breakdown | 2023 | 2022 | 2021 |
|---|---|---|---|
| Operating Cash Flow | -3.75 Billion | -3.38 Billion | -1.82 Billion |
| Net Income | -8.3 Billion | -4.43 Billion | -1.86 Billion |
| Depreciation & Amortization | 296.07 Million | 235.12 Million | - |
| Deferred income taxes | - | - | - |
| Stock-based compensation | -16.89 Million | 98.51 Million | - |
| Change in working capital | -653.63 Million | -460.55 Million | -194.38 Million |
| Other non-cash items | 883.02 Million | 994.33 Million | 237.99 Million |
| Investing Cash Flow | -4.15 Billion | -383.57 Million | -202.62 Million |
| Investments in PPE | -156.35 Million | -314.36 Million | -197.57 Million |
| Acquisitions | - | - | - |
| Investment purchases | -3.95 Billion | - | - |
| Sales/Maturities of investments | - | - | - |
| Other Investing Activities | -52.09 Million | -69.21 Million | -5.05 Million |
| Financing Cash Flow | 6.29 Billion | 1.57 Billion | 5.35 Billion |
| Debt repayment | -406 Million | -286 Million | -663.86 Million |
| Dividends payments | - | - | - |
| Common Stock Repurchased | - | - | - |
| Common Stock Issuance | 6.8 Billion | - | 6 Billion |
| Other Financing Activities | -6.39 Million | 1.54 Billion | 17.24 Million |
| Accounts receivables | -624.75 Million | - | - |
| Accounts payables | 62.16 Million | - | - |
| Inventory | 116.91 Million | -748 Million | - |
| Other working capital | -653.63 Million | -460.55 Million | -194.38 Million |
| Cash at beginning of period | 3.72 Billion | 5.93 Billion | 2.6 Billion |
| Cash at end of period | 2.09 Billion | 3.72 Billion | 5.93 Billion |
| Capital Expenditure | -156.35 Million | -314.36 Million | -197.57 Million |
| Effect of forex changes on cash | -4.15 Million | -4.29 Million | - |
| Net cash flow / Change in cash | -1.62 Billion | -2.2 Billion | 3.32 Billion |
| Free Cash Flow | -3.91 Billion | -3.7 Billion | -2.02 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -2.75 Billion | -1.62 Billion | -8.3 Billion | -740.95 Million | -920.5 Million | -4.43 Billion |
| Depreciation & Amortization | 110.76 Million | 99.5 Million | 296.07 Million | 71.28 Million | 68.55 Million | 235.12 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 49.55 Million | 49.55 Million | -16.89 Million | 51.24 Million | -166.64 Million | 98.51 Million |
| Change in working capital | -989.07 Million | -431.76 Million | -653.63 Million | -462.78 Million | 62.51 Million | -460.55 Million |
| Other non-cash items | 6.07 Million | -17.9 Million | 883.02 Million | 286.36 Million | 245.23 Million | 994.33 Million |
| Investing Cash Flow | 2.25 Billion | 621.76 Million | -4.15 Billion | -6.46 Million | -23.74 Million | -383.57 Million |
| Investments in PPE | -386.77 Million | -378.24 Million | -156.35 Million | -24.46 Million | -23.74 Million | -314.36 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -300 Million | - | -3.95 Billion | - | - | - |
| Sales/Maturities of investments | 2.95 Billion | 1 Billion | - | - | - | - |
| Other Investing Activities | -5.25 Million | -10.00 | -52.09 Million | - | - | -69.21 Million |
| Financing Cash Flow | 20.23 Billion | -44.83 Million | 6.29 Billion | -71.17 Million | -31.47 Million | 1.57 Billion |
| Debt repayment | -46 Million | -9 Million | -406 Million | -49 Million | -9 Million | -286 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 20.31 Billion | - | 6.8 Billion | - | - | - |
| Other Financing Activities | -35.84 Million | - | -6.39 Million | - | - | 1.54 Billion |
| Accounts receivables | -418.82 Million | -122.53 Million | - | - | - | - |
| Accounts payables | -312.71 Million | 369.89 Million | - | - | - | - |
| Inventory | 22.89 Million | -581.38 Million | 116.91 Million | 213.39 Million | 53.36 Million | -748 Million |
| Other working capital | -280.43 Million | -97.74 Million | -653.63 Million | - | - | -460.55 Million |
| Cash at beginning of period | 794.36 Million | 2.09 Billion | 3.72 Billion | 3 Billion | 3.72 Billion | 5.93 Billion |
| Cash at end of period | 19.79 Billion | 794.36 Million | 2.09 Billion | 1.96 Billion | 3 Billion | 3.72 Billion |
| Capital Expenditure | -386.77 Million | -378.24 Million | -156.35 Million | -24.46 Million | -23.74 Million | -314.36 Million |
| Effect of forex changes on cash | 1.61 Million | 2.57 Million | -4.15 Million | - | - | -4.29 Million |
| Net cash flow / Change in cash | 19 Billion | -1.3 Billion | -1.62 Billion | -1.04 Billion | -719.28 Million | -2.2 Billion |
| Free Cash Flow | -3.87 Billion | -2.26 Billion | -3.91 Billion | -986.75 Million | -687.8 Million | -3.7 Billion |
TNDO
AKZOINDIA
NYCB
688519
000990
0LHR